http://www.unboundmedicine.com/medline/ebm/research/bevacizumabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19927266/full_citation/Bevacizumab_in_central_retinal_vein_occlusion:_a_retrospective_analysis_after_2_years_of_treatment_Stahl A, Struebin I, Hansen LL, et al. 
Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment. [JOURNAL ARTICLE]
Eur J Ophthalmol 2009 Nov 13.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19925517/full_citation/Topical_bevacizumab_is_efficacious_in_the_early_bleb_failure_after_trabeculectomy_Z Żarnowski T, Tulidowicz-Bielak M 
Topical bevacizumab is efficacious in the early bleb failure after trabeculectomy. [JOURNAL ARTICLE]
Acta Ophthalmol 2009 Nov 19.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19921473/full_citation/Evaluation_of_Hypertension_as_a_Marker_of_Bevacizumab_Efficacy_Ryanne Wu R, Lindenberg PA, Slack R, et al. 
Evaluation of Hypertension as a Marker of Bevacizumab Efficacy. [JOURNAL ARTICLE]
J Gastrointest Cancer 2009 Nov 18.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19920819/full_citation/Metronomic_chemotherapy_with_daily_oral_etoposide_plus_bevacizumab_for_recurrent_malignant_glioma:_a_phase_II_study_Reardon DA, Desjardins A, Vredenburgh JJ, et al. 
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. [JOURNAL ARTICLE]
Br J Cancer 2009 Nov 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19920817/full_citation/Costs_of_managing_adverse_events_in_the_treatment_of_first_line_metastatic_renal_cell_carcinoma:_bevacizumab_in_combination_with_interferon_alpha2a_compared_with_sunitinib_Mickisch G, Gore M, Escudier B, et al. 
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib. [JOURNAL ARTICLE]
Br J Cancer 2009 Nov 17.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917990/full_citation/Bevacizumab_for_recurrent_ependymoma_Green RM, Cloughesy TF, Stupp R, et al. 
Bevacizumab for recurrent ependymoma. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Neurology 2009 Nov 17; 73(20):1677-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917871/full_citation/American_Society_of_Clinical_Oncology_Clinical_Practice_Guideline_Update_on_Chemotherapy_for_Stage_IV_Non_Small_Cell_Lung_Cancer_Azzoli CG, Baker S, Temin S, et al. 
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19917843/full_citation/Phase_II_Study_of_Carboplatin_Paclitaxel_and_Bevacizumab_With_Maintenance_Bevacizumab_As_First_Line_Chemotherapy_for_Advanced_Mullerian_Tumors_Penson RT, Dizon DS, Cannistra SA, et al. 
Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Mullerian Tumors. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19916212/full_citation/Non_arteritic_anterior_ischemic_optic_neuropathy__NA_AION__after_intravitreal_injection_of_bevacizumab__Avastin__for_treatment_of_angoid_streaks_in_pseudoxanthoma_elasticum_Ganssauge M, Wilhelm H, Bartz-Schmidt KU, et al. 
Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum. [Journal Article]
Graefes Arch Clin Exp Ophthalmol 2009 Dec; 247(12):1707-10.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19914732/full_citation/Targeted_therapies_for_non_small_cell_lung_cancer_Dempke WC, Suto T, Reck M 
Targeted therapies for non-small cell lung cancer. [JOURNAL ARTICLE]
Lung Cancer 2009 Nov 13.
Abstract | Full Citation | Find Related Articles